Modular Medical, Inc. reports that 683 Capital Partners, LP (through its manager 683 Capital Management, LLC and Managing Member Ari Zweiman) beneficially owned 125,001 common shares and warrants exercisable for 134,239 shares. The filing states this position represents approximately 4.67% of the outstanding common stock, based on 5,411,177 shares outstanding as of April 21, 2026, with the 4.67% figure given as of May 15, 2026.
Positive
None.
Negative
None.
Insights
Ownership disclosure shows a sub-5% position including exercisable warrants.
The filing details that 125,001 shares are held and 134,239 shares are issuable upon exercise of currently exercisable warrants, and it calculates ownership using 5,411,177 shares outstanding as of April 21, 2026.
Subsequent filings or transactions would change the percentage; the cash‑flow treatment or intent for the warrants is not described in the excerpt.
Schedule 13G/A properly attributes beneficial ownership across manager and managing member.
The disclosure explains that 683 Capital Management, LLC and Ari Zweiman may be deemed beneficial owners of the shares and exercisable warrants held by 683 Capital Partners, LP, consistent with group attribution rules.
Filing signatures show authorization by Ari Zweiman on May 15, 2026; any changes in holdings should be reported in amended schedules.
Key Figures
Common shares beneficially owned:125,001 sharesWarrants exercisable:134,239 sharesOwnership percentage:4.67%+1 more
4 metrics
Common shares beneficially owned125,001 sharesheld by 683 Capital Partners, LP as of March 31, 2026
Warrants exercisable134,239 shareswarrants currently exercisable held by the Reporting Persons
Ownership percentage4.67%Reporting Persons' beneficial ownership as of May 15, 2026
Shares outstanding used5,411,177 sharesoutstanding as of April 21, 2026 per issuer Form S-3
"As of March 31, 2026, 683 Capital Partners, LP beneficially owned 125,001 Common Shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
warrants exercisablefinancial
"warrants to purchase 134,239 shares of Common Stock which are currently exercisable"
Schedule 13G/Aregulatory
"Modular Medical, Inc. Common Stock ... (Amendment No. 1 )"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google
What stake does 683 Capital Partners report in Modular Medical (MODD)?
They report beneficial ownership of 125,001 common shares and warrants exercisable for 134,239 shares. The filing states this aggregated position equates to approximately 4.67% of outstanding shares as of May 15, 2026.
How many Modular Medical shares were outstanding for the ownership calculation?
The filing uses 5,411,177 common shares outstanding as of April 21, 2026. That outstanding count plus the 134,239 exercisable warrants is the basis for the 4.67% ownership calculation reported.
Who may be deemed to beneficially own the reported shares and warrants?
The filing states 683 Capital Management, LLC (manager) and Ari Zweiman (Managing Member) may be deemed to beneficially own the shares and warrants held by 683 Capital Partners, LP. Ownership attribution is described in Item 4.
Are the warrants exercisable or merely issuable in this disclosure?
The filing describes the instruments as warrants to purchase 134,239 shares of Common Stock which are currently exercisable. No further terms of those warrants are provided in the excerpt.
When was the Schedule 13G/A signed and by whom?
The form is signed and dated 05/15/2026 with signature(s) by Ari Zweiman in multiple authorized capacities. The filing shows authorization and signature blocks executed on that date.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Modular Medical, Inc.
(Name of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
60785L207
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
60785L207
1
Names of Reporting Persons
683 Capital Management, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
259,240.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
259,240.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
259,240.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.67 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
60785L207
1
Names of Reporting Persons
683 Capital Partners, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
259,240.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
259,240.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
259,240.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.67 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
60785L207
1
Names of Reporting Persons
Ari Zweiman
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
259,240.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
259,240.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
259,240.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.67 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Modular Medical, Inc.
(b)
Address of issuer's principal executive offices:
10740 THORNMINT ROAD, SAN DIEGO, CALIFORNIA
92127
Item 2.
(a)
Name of person filing:
683 Capital Management, LLC
683 Capital Partners, LP
Ari Zweiman
Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons."
(b)
Address or principal business office or, if none, residence:
The principal business address for each of the Reporting Persons is 1700 Broadway, Suite 4200, New York, New York 10019.
(c)
Citizenship:
683 Capital Management, LLC - DELAWARE
683 Capital Partners, LP - DELAWARE
Ari Zweiman - UNITED STATES
(d)
Title of class of securities:
Common Stock, $0.001 par value per share
(e)
CUSIP No.:
60785L207
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of March 31, 2026, 683 Capital Partners, LP beneficially owned 125,001 Common Shares and warrants to purchase 134,239 shares of Common Stock which are currently exercisable.
683 Capital Management, LLC, as the investment manager of 683 Capital Partners, LP, may be deemed to have beneficially owned the 125,001 Common Shares and warrants to purchase 134,239 shares of Common Stock beneficially owned by 683 Capital Partners, LP.
Ari Zweiman, as the Managing Member of 683 Capital Management, LLC, may be deemed to have beneficially owned the 125,001 Common Shares and warrants to purchase 134,239 shares of Common Stock beneficially owned by 683 Capital Management, LLC.
The following percentage is based on 5,411,177 Common Shares outstanding as of April 21, 2026, as disclosed in the Issuer's Form S-3 filed on April 23, 2026 plus 134,239 shares of Common Stock issuable upon exercise of currently exercisable warrants held by the Reporting Persons.
As of May 15, 2026, the Reporting Persons may be deemed to have beneficially owned approximately 4.67% of the outstanding Common Shares.
(b)
Percent of class:
4.67 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See Cover Pages Items 5-9.
(ii) Shared power to vote or to direct the vote:
See Cover Pages Items 5-9.
(iii) Sole power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
(iv) Shared power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
See Exhibit A to Schedule 13G as filed on March 10, 2026.
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
